Evidence map›Paper›PMID 34512930›Full record

ReviewJournal of nanostructure in chemistry2022

Graphene and its derivatives: understanding the main chemical and medicinal chemistry roles for biomedical applications.

Tais Monteiro Magne, Thamires de Oliveira Vieira, Luciana Magalhães Rebelo Alencar, Francisco Franciné Maia Junior, Sara Gemini-Piperni, Samuel V Carneiro, Lillian M U D Fechine, Rafael M Freire, Kirill Golokhvast, Pierangelo Metrangolo and 2 more

Abstract readReview
In one paragraph

Review in Journal of nanostructure in chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Biochar-based electrochemical sensors: a tailored approach to environmental monitoring.Analytical sciences : the international journal of the Japan Society for Analytical Chemistry · 2025
    Review
  6. Synthesis of Graphene@CPharmaceutical nanotechnology · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Graphene in 3D Bioprinting.Journal of functional biomaterials · 2024
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Tais Monteiro MagneBrazilian Nuclear Energy Commission, Nuclear Engineering Institute, Rio de Janeiro, 21941906 Brazil.
Thamires de Oliveira VieiraBrazilian Nuclear Energy Commission, Nuclear Engineering Institute, Rio de Janeiro, 21941906 Brazil.
Luciana Magalhães Rebelo AlencarBiophysics and Nanosystems Laboratory, Department of Physics, Federal University of Maranhão, São Luis, Maranhão 65080805 Brazil.
Francisco Franciné Maia JuniorDepartment of Natural Sciences, Mathematics and Statistics, Federal Rural University of the Semi-Arid, Mossoró, RN 59625-900 Brazil.
Sara Gemini-PiperniLaboratory of Advanced Science, Universidade Unigranrio, Duque de Caxias, RJ 25071-202 Brazil.
Samuel V CarneiroGroup of Chemistry of Advanced Materials (GQMat)-Department of Analytical Chemistry and Physic-Chemistry, Federal University of Ceará-Campus do Pici, Fortaleza, Ceará 60451-970 Brazil.
Lillian M U D FechineGroup of Chemistry of Advanced Materials (GQMat)-Department of Analytical Chemistry and Physic-Chemistry, Federal University of Ceará-Campus do Pici, Fortaleza, Ceará 60451-970 Brazil.
Rafael M FreireInstitute of Applied Chemical Sciences, Universidad Autónoma de Chile, 8910060 Santiago, Chile.
Kirill GolokhvastEducation and Scientific Center of Nanotechnology, School of Engineering, Far Eastern Federal University, Vladivostok, Russia.
Pierangelo MetrangoloLaboratory of Supramolecular and Bio-Nanomaterials, Department of Chemistry, Materials, and Chemical Engineering "Giulio Natta" Politecnico Di Milano, Via L. Mancinelli 7, 20131 Milano, Italy.
Pierre B A FechineGroup of Chemistry of Advanced Materials (GQMat)-Department of Analytical Chemistry and Physic-Chemistry, Federal University of Ceará-Campus do Pici, Fortaleza, Ceará 60451-970 Brazil.
Ralph Santos-OliveiraBrazilian Nuclear Energy Commission, Nuclear Engineering Institute, Rio de Janeiro, 21941906 Brazil.ORCID 0000-0002-7221-6404

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Over the past few years, there has been a growing potential use of graphene and its derivatives in several biomedical areas, such as drug delivery systems, biosensors, and imaging systems, especially for having excellent optical, electronic, thermal, and mechanical properties. Therefore, nanomaterials in the graphene family have shown promising results in several areas of science. The different physicochemical properties of graphene and its derivatives guide its biocompatibility and toxicity. Hence, further studies to explain the interactions of these nanomaterials with biological systems are fundamental. This review has shown the applicability of the graphene family in several biomedical modalities, with particular attention for cancer therapy and diagnosis, as a potent theranostic. This ability is derivative from the considerable number of forms that the graphene family can assume. The graphene-based materials biodistribution profile, clearance, toxicity, and cytotoxicity, interacting with biological systems, are discussed here, focusing on its synthesis methodology, physicochemical properties, and production quality. Despite the growing increase in the bioavailability and toxicity studies of graphene and its derivatives, there is still much to be unveiled to develop safe and effective formulations. Graphic abstract:

Indexed as

CarbonGrapheneNanomaterialsNanomedicineNanoparticles

Identifiers

PMID34512930
PMCPMC8419677

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.